assessment for advanced liver fibrosis in people with NAFLD
Last reviewed 09/2021
Assessment for advanced liver fibrosis in people with NAFLD
Identifying people with advanced liver fifibrosis
- testing should be offered for advanced liver fibrosis to people with NAFLD
- consider using the enhanced liver fibrosis (ELF) test in people who have been diagnosed with NAFLD to test for advanced liver fibrosis
- do not use routine liver blood tests to assess for advanced liver fibrosis
in people with NAFLD
- diagnose people with advanced liver fibrosis if they have:
- an ELF score of 10.51 or above
- and NAFLD
- refer adults and young people diagnosed with advanced liver fibrosis to
a relevant specialist in hepatology
- if an ELF score below 10.51 then:
- explain that are unlikely to have advanced liver fibrosis
- reassessment for advanced liver fibrosis every 3 years for adults and every 2 years for children and young people is sufficient for regular monitoring
- no interim tests are needed
- consider using ELF for retesting people with advanced liver fibrosis
Extra-hepatic conditions
- NAFLD is a risk factor for type 2 diabetes, hypertension and chronic kidney disease
- in people with type 2 diabetes, NAFLD is a risk factor for atrial fibrillation, myocardial infarction, ischaemic stroke and death from cardiovascular causes
Reference:
ELF test for liver fibrosis in NAFLD (non - alcoholic fatty liver disease)